These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27599377)

  • 1. Impact of comorbidities on the cost of depression drug therapy in general practices in Germany.
    Jacob L; Kostev K
    J Psychiatr Res; 2016 Dec; 83():130-136. PubMed ID: 27599377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study.
    Gill JM; Klinkman MS; Chen YX
    J Am Board Fam Med; 2010; 23(4):499-508. PubMed ID: 20616292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization.
    Fischer LR; Wei F; Rolnick SJ; Jackson JM; Rush WA; Garrard JM; Nitz NM; Luepke LJ
    J Am Geriatr Soc; 2002 Feb; 50(2):307-12. PubMed ID: 12028213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Patterns and the Cost of Migraine Treatments in German General and Neurological Practices.
    Jacob L; Kostev K
    Pain Pract; 2017 Jul; 17(6):747-752. PubMed ID: 27622427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age effects on treatment patterns in 138,097 patients with unipolar depression followed in general practices in Germany.
    Mössinger H; Kostev K
    J Psychiatr Res; 2021 Dec; 144():208-216. PubMed ID: 34700208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
    Jacob L; von Vultee C; Kostev K
    J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
    Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
    J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of antidepressant treatment duration in naturalistic conditions.
    Tournier M; Crott R; Gaudron Y; Verdoux H
    Acta Psychiatr Scand; 2013 May; 127(5):365-72. PubMed ID: 23176590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic costs of antidepressant use: a population-based study in Sweden.
    Beckman L; von Kobyletzki L; Svensson M
    J Ment Health Policy Econ; 2019 Dec; 22(4):125-130. PubMed ID: 32058977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease.
    Bach JP; Riedel O; Klotsche J; Spottke A; Dodel R; Wittchen HU
    J Neurol Sci; 2012 Mar; 314(1-2):41-7. PubMed ID: 22133477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic disparities in antidepressant drug use.
    Chen J; Rizzo JA
    J Ment Health Policy Econ; 2008 Dec; 11(4):155-65. PubMed ID: 19096090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The costs of depression and the cost-effectiveness of treatment].
    König HH; Luppa M; Riedel-Heller S
    Psychiatr Prax; 2010 Jul; 37(5):213-5. PubMed ID: 20597034
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data.
    Bramesfeld A; Grobe T; Schwartz FW
    Soc Psychiatry Psychiatr Epidemiol; 2010 Mar; 45(3):329-35. PubMed ID: 19452107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood predictors of use and costs of antidepressant medication by age 24 years: findings from the Finnish Nationwide 1981 Birth Cohort Study.
    Gyllenberg D; Sourander A; Niemelä S; Helenius H; Sillanmäki L; Ristkari T; Piha J; Kumpulainen K; Tamminen T; Moilanen I; Almqvist F
    J Am Acad Child Adolesc Psychiatry; 2011 Apr; 50(4):406-15, 415.e1. PubMed ID: 21421180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
    Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
    J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and benefits of improving access to psychotherapies for common mental disorders.
    Dezetter A; Briffault X; Ben Lakhdar C; Kovess-Masfety V
    J Ment Health Policy Econ; 2013 Dec; 16(4):161-77. PubMed ID: 24526585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant treatment patterns in younger and older adults from the general population in a real-life setting.
    Etchepare F; Sanglier T; André M; Verdoux H; Tournier M
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):928-35. PubMed ID: 24477963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of a medical-offset effect among patients receiving antidepressant therapy.
    Thompson D; Hylan TR; McMullen W; Romeis ME; Buesching D; Oster G
    Am J Psychiatry; 1998 Jun; 155(6):824-7. PubMed ID: 9619157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.